[
  {
    "title": "亿帆医药(002019.SZ)：子公司获得政府补助3735.12万元",
    "href": "http://stock.jrj.com.cn/2022/12/22192137232263.shtml",
    "datetime": "2022-12-22 19:21:17",
    "code": "002019"
  },
  {
    "title": "亿帆医药：涉疫产品订单量充足，将对业绩产生正面影响",
    "href": "http://stock.jrj.com.cn/2022/12/18213437220951.shtml",
    "datetime": "2022-12-18 21:34:46",
    "code": "002019"
  },
  {
    "title": "A股异动 | 亿帆医药一度涨8% 控股子公司签署独家许可协议 获不超2.37亿美元",
    "href": "http://stock.jrj.com.cn/2022/11/15094037139244.shtml",
    "datetime": "2022-11-15 09:40:30",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司将在研产品F-627在美国的独家经销权许可给ACROTECH公司",
    "href": "http://stock.jrj.com.cn/2022/11/14220237138605.shtml",
    "datetime": "2022-11-14 22:02:20",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2.37亿美元将F-627在美国的独家经销权许可给ACROTECH公司",
    "href": "http://stock.jrj.com.cn/2022/11/14173637137514.shtml",
    "datetime": "2022-11-14 17:36:53",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：2022年员工持股计划已完成购买729.21万股",
    "href": "http://stock.jrj.com.cn/2022/11/07194237118236.shtml",
    "datetime": "2022-11-07 19:42:31",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：第三季度净利4269.60万元，同比下降45.00%",
    "href": "http://stock.jrj.com.cn/2022/10/28181037094703.shtml",
    "datetime": "2022-10-28 18:10:50",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：2022年员工持股计划已累计购买396.09万股",
    "href": "http://stock.jrj.com.cn/2022/10/14170937056430.shtml",
    "datetime": "2022-10-14 17:09:47",
    "code": "002019"
  },
  {
    "title": "亿帆医药副总裁王杰辞职 2022上半年公司净利1.61亿",
    "href": "http://stock.jrj.com.cn/2022/10/09193137042189.shtml",
    "datetime": "2022-10-09 19:31:25",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：复方银花解毒颗粒获得新加坡注册批文",
    "href": "http://stock.jrj.com.cn/2022/09/27183537025510.shtml",
    "datetime": "2022-09-27 18:35:13",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)上半年净利1.61亿元，同比下降24.67%",
    "href": "http://stock.jrj.com.cn/2022/08/30202636954349.shtml",
    "datetime": "2022-08-30 20:26:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：乳果糖口服溶液获批上市",
    "href": "http://stock.jrj.com.cn/2022/08/17171236908381.shtml",
    "datetime": "2022-08-17 17:12:56",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：二氮嗪口服混悬液境内注册上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2022/08/03174336867354.shtml",
    "datetime": "2022-08-03 17:43:58",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿一生物完成融资7000万美元",
    "href": "http://stock.jrj.com.cn/2022/07/06220836788654.shtml",
    "datetime": "2022-07-06 22:08:22",
    "code": "002019"
  },
  {
    "title": "亿帆医药增资亿一生物，释放了怎样的信号？",
    "href": "http://stock.jrj.com.cn/2022/06/14084336726300.shtml",
    "datetime": "2022-06-14 08:43:40",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东程先锋解质2177万股",
    "href": "http://stock.jrj.com.cn/2022/06/09200236717094.shtml",
    "datetime": "2022-06-09 20:02:07",
    "code": "002019"
  },
  {
    "title": "亿帆医药控股股东程先锋质押2100万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/06/08221036714084.shtml",
    "datetime": "2022-06-08 22:10:43",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东程先锋质押2100万股",
    "href": "http://stock.jrj.com.cn/2022/06/08193536713539.shtml",
    "datetime": "2022-06-08 19:35:09",
    "code": "002019"
  },
  {
    "title": "A股异动 | 五矿发展涨停 中国五矿正研究有关承诺亿帆医药变更事项方案",
    "href": "http://stock.jrj.com.cn/2022/06/02093936699252.shtml",
    "datetime": "2022-06-02 09:39:10",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿一生物拟融资7000万美元、由中国生物制药投资2000万美元",
    "href": "http://stock.jrj.com.cn/2022/06/01210236698334.shtml",
    "datetime": "2022-06-01 21:02:47",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿帆制药的普乐沙福注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/05/30183236690437.shtml",
    "datetime": "2022-05-30 18:32:41",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年净利润2.8亿元同比降71%：市场推广费成为“吃”利润大户",
    "href": "http://stock.jrj.com.cn/2022/04/14121236333417.shtml",
    "datetime": "2022-04-14 12:12:54",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年净利2.78亿同比下滑71.25% 董事长程先锋薪酬62.4万",
    "href": "http://stock.jrj.com.cn/2022/04/13051136319997.shtml",
    "datetime": "2022-04-13 05:11:23",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：拟继续使用不超5亿元闲置募资进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/04/12205836317383.shtml",
    "datetime": "2022-04-12 20:58:26",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)子公司拟使用不超20亿元自有资金进行委托理财",
    "href": "http://stock.jrj.com.cn/2022/04/12205636317386.shtml",
    "datetime": "2022-04-12 20:56:42",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：2021年度净利降71.25%至2.78亿元",
    "href": "http://stock.jrj.com.cn/2022/04/12205436317389.shtml",
    "datetime": "2022-04-12 20:54:28",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿帆研究院再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2022/03/09191134594459.shtml",
    "datetime": "2022-03-09 19:11:49",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东程先锋质押展期2250万股",
    "href": "http://stock.jrj.com.cn/2022/02/28203734501795.shtml",
    "datetime": "2022-02-28 20:37:39",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司将在研产品F-627在德国的独家经销权许可给APOGEPHA公司",
    "href": "http://stock.jrj.com.cn/2022/02/28203234501753.shtml",
    "datetime": "2022-02-28 20:32:19",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司盐酸去氧肾上腺素注射液境内注册上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2022/02/17184134382724.shtml",
    "datetime": "2022-02-17 18:41:32",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司注射用头孢呋辛钠通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/14201834346147.shtml",
    "datetime": "2022-02-14 20:18:35",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年预计净利2.2亿-3.2亿同比下降77%-67% 原料药业务主要产品价格下降",
    "href": "http://stock.jrj.com.cn/2022/01/30095334258724.shtml",
    "datetime": "2022-01-30 09:53:01",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：盐酸替罗非班注射液获得药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2022/01/25191034213502.shtml",
    "datetime": "2022-01-25 19:10:13",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司收到盐酸多巴胺注射液境内注册上市许可申请受理通知书",
    "href": "http://stock.jrj.com.cn/2022/01/12192634151005.shtml",
    "datetime": "2022-01-12 19:26:46",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：盐酸氨溴索注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/01/07192334134612.shtml",
    "datetime": "2022-01-07 19:23:38",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：178.65万股限制性股票1月11日解锁上市",
    "href": "http://stock.jrj.com.cn/2022/01/06182834130443.shtml",
    "datetime": "2022-01-06 18:28:57",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿帆制药通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/12/15181034020353.shtml",
    "datetime": "2021-12-15 18:10:54",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：股份回购方案已实施完成 累计回购722.1842万股",
    "href": "http://stock.jrj.com.cn/2021/11/30174233944857.shtml",
    "datetime": "2021-11-30 17:42:07",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司四川德峰再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/11/29173733938582.shtml",
    "datetime": "2021-11-29 17:37:28",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：Bioton生产的人胰岛素注射液产品中的3个产品均以A类排名拟中选集采",
    "href": "http://stock.jrj.com.cn/2021/11/26195133924877.shtml",
    "datetime": "2021-11-26 19:51:29",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：10月未回购股份",
    "href": "http://stock.jrj.com.cn/2021/11/02160433803504.shtml",
    "datetime": "2021-11-02 16:04:14",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)第三季度净利润预降53.34%-68.9%",
    "href": "http://stock.jrj.com.cn/2021/10/14203833693041.shtml",
    "datetime": "2021-10-14 20:38:29",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年前三季度预计净利2.73亿元–3.03亿元 比上年同期减少70%–67%",
    "href": "http://stock.jrj.com.cn/2021/10/14202533693008.shtml",
    "datetime": "2021-10-14 20:25:43",
    "code": "002019"
  },
  {
    "title": "A股异动 | 亿帆医药(002019.SZ)涨约4% 在研产品F-627上市申请获得EMA正式受理",
    "href": "http://stock.jrj.com.cn/2021/10/08103133656273.shtml",
    "datetime": "2021-10-08 10:31:37",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：在研产品F-627上市申请获得EMA正式受理",
    "href": "http://stock.jrj.com.cn/2021/10/07232633649819.shtml",
    "datetime": "2021-10-07 23:26:44",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：9月8日首次回购150万股",
    "href": "http://stock.jrj.com.cn/2021/09/08173133404833.shtml",
    "datetime": "2021-09-08 17:31:03",
    "code": "002019"
  },
  {
    "title": "亿帆医药：F-652新增适应症慢加急性肝衰竭获批开展II期临床试验",
    "href": "http://stock.jrj.com.cn/2021/09/07205533400106.shtml",
    "datetime": "2021-09-07 20:55:45",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：在研产品F-652新增适应症慢加急性肝衰竭获批开展II期临床试验",
    "href": "http://stock.jrj.com.cn/2021/09/07200633399894.shtml",
    "datetime": "2021-09-07 20:06:29",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：截至8月底尚未开始回购股份",
    "href": "http://stock.jrj.com.cn/2021/09/02171633374828.shtml",
    "datetime": "2021-09-02 17:16:35",
    "code": "002019"
  },
  {
    "title": "亿帆医药将花不超1.5亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/08/30220733355609.shtml",
    "datetime": "2021-08-30 22:07:26",
    "code": "002019"
  },
  {
    "title": "亿帆医药拟1亿元-1.5亿元回购股份，将用于股权激励或员工持股计划",
    "href": "http://stock.jrj.com.cn/2021/08/30114633350943.shtml",
    "datetime": "2021-08-30 11:46:45",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)拟1亿元-1.5亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/08/29234333341956.shtml",
    "datetime": "2021-08-29 23:43:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：上半年净利降70.33%至2.13亿元",
    "href": "http://stock.jrj.com.cn/2021/08/29211533341727.shtml",
    "datetime": "2021-08-29 21:15:43",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年半年度净利2.13亿元 同比净利减少70.33%",
    "href": "http://stock.jrj.com.cn/2021/08/29201633341543.shtml",
    "datetime": "2021-08-29 20:16:08",
    "code": "002019"
  },
  {
    "title": "亿帆医药：将F-627相关的商业化权益许可给天晴南京顺欣",
    "href": "http://stock.jrj.com.cn/2021/08/29171133340742.shtml",
    "datetime": "2021-08-29 17:11:36",
    "code": "002019"
  },
  {
    "title": "【天风医药】亿帆医药（002019）首次覆盖：创新药业务纵横四海，制剂业务保驾护航",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/20113533285922.shtml",
    "datetime": "2021-08-20 11:35:25",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：子公司收到氯法拉滨注射液境内注册上市许可申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/08/02214633190913.shtml",
    "datetime": "2021-08-02 21:46:33",
    "code": "002019"
  },
  {
    "title": "亿帆医药原料药价陡降半年净利预减七成 两年六项研发失败22亿资本化研发存风险",
    "href": "http://stock.jrj.com.cn/2021/07/26071933152685.shtml",
    "datetime": "2021-07-26 07:19:52",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：收到药品交联玻璃酸钠注射液的注册受理通知书",
    "href": "http://stock.jrj.com.cn/2021/07/22201233136711.shtml",
    "datetime": "2021-07-22 20:12:43",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年上半年预计净利1.8亿-2.51亿下降65%-75% 海外业务利润下降",
    "href": "http://stock.jrj.com.cn/2021/07/12224933084759.shtml",
    "datetime": "2021-07-12 22:49:44",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：624.075万股限制性股票将于7月15日上市流通",
    "href": "http://stock.jrj.com.cn/2021/07/12214733084559.shtml",
    "datetime": "2021-07-12 21:47:46",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)半年度净利润预降65%-75%",
    "href": "http://stock.jrj.com.cn/2021/07/12182833083668.shtml",
    "datetime": "2021-07-12 18:28:13",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：可解除限售的限制性股票为624.08万股",
    "href": "http://stock.jrj.com.cn/2021/06/24192032991070.shtml",
    "datetime": "2021-06-24 19:20:19",
    "code": "002019"
  },
  {
    "title": "亿帆医药：如2021年业绩未达到股权激励解除限售条件 将进行回购注销",
    "href": "http://stock.jrj.com.cn/2021/06/23111132981704.shtml",
    "datetime": "2021-06-23 11:11:24",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司全资子公司杭州鑫富主营产品之一生物降解材料是综合性能较好的全生物降解材料",
    "href": "http://stock.jrj.com.cn/2021/06/22230132979505.shtml",
    "datetime": "2021-06-22 23:01:16",
    "code": "002019"
  },
  {
    "title": "亿帆医药：F-627的美国商业合作伙伴遴选工作在正常推进中",
    "href": "http://stock.jrj.com.cn/2021/06/22230032979498.shtml",
    "datetime": "2021-06-22 23:00:39",
    "code": "002019"
  },
  {
    "title": "亿帆医药：亿一生物的Pre-IPO融资以及商业合作伙伴工作均在正常进行中",
    "href": "http://stock.jrj.com.cn/2021/06/22225932978874.shtml",
    "datetime": "2021-06-22 22:59:33",
    "code": "002019"
  },
  {
    "title": "亿帆医药：截止2021年6月20日 公司持有亿一生物股权比例为66.49%",
    "href": "http://stock.jrj.com.cn/2021/06/22225832978878.shtml",
    "datetime": "2021-06-22 22:58:11",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东程先锋质押的2177万股展期",
    "href": "http://stock.jrj.com.cn/2021/06/14232232928733.shtml",
    "datetime": "2021-06-14 23:22:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东程先锋解质1400万股",
    "href": "http://stock.jrj.com.cn/2021/06/08213832895808.shtml",
    "datetime": "2021-06-08 21:38:25",
    "code": "002019"
  },
  {
    "title": "亿帆医药控股股东程先锋质押1500万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2021/06/07213332889005.shtml",
    "datetime": "2021-06-07 21:33:41",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司2019年限制性股票激励计划首次授予部分第二个解除限售期将于2021年6月18日届满",
    "href": "http://stock.jrj.com.cn/2021/06/07203832888699.shtml",
    "datetime": "2021-06-07 20:38:17",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SH)：控股股东程先锋质押1500万股",
    "href": "http://stock.jrj.com.cn/2021/06/07184532887843.shtml",
    "datetime": "2021-06-07 18:45:50",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前生物药尚未进入集采 而且F-627实现了新型结构",
    "href": "http://stock.jrj.com.cn/2021/06/02204032865335.shtml",
    "datetime": "2021-06-02 20:40:06",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前在研产品F-627没有进行其他适应症的临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/02203932865337.shtml",
    "datetime": "2021-06-02 20:39:58",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前亿一生物的融资工作和在研产品F-627商业合作伙伴的选择均在稳步推进中",
    "href": "http://stock.jrj.com.cn/2021/06/02203832865303.shtml",
    "datetime": "2021-06-02 20:38:48",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司暂未确定对医美产品业务的新规划",
    "href": "http://stock.jrj.com.cn/2021/06/02203832865304.shtml",
    "datetime": "2021-06-02 20:38:40",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司没有涉及新型冠状病毒肺炎疫苗的销售",
    "href": "http://stock.jrj.com.cn/2021/06/02203232865282.shtml",
    "datetime": "2021-06-02 20:32:11",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司子公司四川德峰药业有限公司生产金樱首乌汁产品 功能主治养血益肝 强筋健骨 乌须黑发",
    "href": "http://stock.jrj.com.cn/2021/05/31195132851961.shtml",
    "datetime": "2021-05-31 19:51:54",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前断金戒毒胶囊在研产品正处于多剂量递增Ib期临床试验中",
    "href": "http://stock.jrj.com.cn/2021/05/31194432851870.shtml",
    "datetime": "2021-05-31 19:44:35",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2019年限制性股票激励计划的授予价格为6.66元/股",
    "href": "http://stock.jrj.com.cn/2021/05/31193632851813.shtml",
    "datetime": "2021-05-31 19:36:38",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前医美产品属于公司非核心主营业务收入占比不高",
    "href": "http://stock.jrj.com.cn/2021/05/31184032851499.shtml",
    "datetime": "2021-05-31 18:40:59",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前公司持有海南希睿达生物技术有限公司51%股份",
    "href": "http://stock.jrj.com.cn/2021/05/31184032851503.shtml",
    "datetime": "2021-05-31 18:40:53",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：FDA正式接受F-627的上市申请",
    "href": "http://stock.jrj.com.cn/2021/05/28172032835881.shtml",
    "datetime": "2021-05-28 17:20:27",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前公司没有在“口服胰岛素”方面的研究",
    "href": "http://stock.jrj.com.cn/2021/05/26213032825564.shtml",
    "datetime": "2021-05-26 21:30:31",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司没有生产新冠疫苗的原料药或者疫苗相关业务",
    "href": "http://stock.jrj.com.cn/2021/05/26211732825506.shtml",
    "datetime": "2021-05-26 21:17:20",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)2020年度权益分派10派0.5元 股权登记日为5月14日",
    "href": "http://stock.jrj.com.cn/2021/05/06195732703039.shtml",
    "datetime": "2021-05-06 19:57:36",
    "code": "002019"
  },
  {
    "title": "亿帆医药：亿帆生物未达到10%的主要原因是其下属子公司分红收入同比减少所致",
    "href": "http://stock.jrj.com.cn/2021/04/29092132477905.shtml",
    "datetime": "2021-04-29 09:21:28",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)一季度净利降59.11%至1.32亿元",
    "href": "http://stock.jrj.com.cn/2021/04/28235432475012.shtml",
    "datetime": "2021-04-28 23:54:07",
    "code": "002019"
  },
  {
    "title": "亿帆医药：三代胰岛素类似物开发和申请主体为亿帆医药或全资控股子公司",
    "href": "http://stock.jrj.com.cn/2021/04/15195032381292.shtml",
    "datetime": "2021-04-15 19:50:13",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司有玻尿酸产品",
    "href": "http://stock.jrj.com.cn/2021/04/15193732381203.shtml",
    "datetime": "2021-04-15 19:37:53",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前在研产品F-652关于急性胰腺炎的适应症正在按计划开展",
    "href": "http://stock.jrj.com.cn/2021/04/15192932381159.shtml",
    "datetime": "2021-04-15 19:29:41",
    "code": "002019"
  },
  {
    "title": "亿帆医药2021年一季度预计净利下降60%-45% 维生素系列产品价格下降较大",
    "href": "http://stock.jrj.com.cn/2021/04/13134732364237.shtml",
    "datetime": "2021-04-13 13:47:21",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)一季度净利润预降45%-60%",
    "href": "http://stock.jrj.com.cn/2021/04/12222332360044.shtml",
    "datetime": "2021-04-12 22:23:56",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年净利增长7.19%：董事长程先锋薪酬62.4万",
    "href": "http://stock.jrj.com.cn/2021/03/31195132257858.shtml",
    "datetime": "2021-03-31 19:51:07",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)2020年度净利润升7.19%至9.68亿元 拟10派0.5元",
    "href": "http://stock.jrj.com.cn/2021/03/31001232251118.shtml",
    "datetime": "2021-03-31 00:12:11",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：亿帆研究院“F-899”获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/12195332122288.shtml",
    "datetime": "2021-03-12 19:53:09",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东质押2250万股及解押3380万股",
    "href": "http://stock.jrj.com.cn/2021/02/28180832040584.shtml",
    "datetime": "2021-02-28 18:08:25",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：拟使用闲置募集资金6亿元用于暂补流动资金",
    "href": "http://stock.jrj.com.cn/2021/02/25185532027176.shtml",
    "datetime": "2021-02-25 18:55:44",
    "code": "002019"
  },
  {
    "title": "【龙虎榜】亿帆医药1月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/28180031802129.shtml",
    "datetime": "2021-01-28 18:00:30",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药取得爱克兰中国独家许可权利",
    "href": "http://stock.jrj.com.cn/2021/01/28000031801578.shtml",
    "datetime": "2021-01-28 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药旗下四公司再获高新技术企业认证",
    "href": "http://stock.jrj.com.cn/2021/01/25000031764238.shtml",
    "datetime": "2021-01-25 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：全资公司再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/19182731723149.shtml",
    "datetime": "2021-01-19 18:27:16",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司全资子公司杭州鑫富主营产品之一生物降解材料目前订单充足",
    "href": "http://stock.jrj.com.cn/2021/01/15182331700450.shtml",
    "datetime": "2021-01-15 18:23:10",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：全资公司再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/11201931672033.shtml",
    "datetime": "2021-01-11 20:19:15",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]眉山市经信局局长彭盆一行莅临德峰药业开展重点项目建设检查",
    "href": "http://stock.jrj.com.cn/2021/01/08000031656913.shtml",
    "datetime": "2021-01-08 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：239.2万股限制性股票1月13日解禁",
    "href": "http://stock.jrj.com.cn/2021/01/07180831649132.shtml",
    "datetime": "2021-01-07 18:08:47",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：239.20万股限制性股票解除限售条件成就",
    "href": "http://stock.jrj.com.cn/2021/01/04190931628690.shtml",
    "datetime": "2021-01-04 19:09:38",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：控股股东解除质押1400万股",
    "href": "http://stock.jrj.com.cn/2021/01/03194331622341.shtml",
    "datetime": "2021-01-03 19:43:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：目前尚无有效的治疗方案",
    "href": "http://stock.jrj.com.cn/2020/12/31192931614667.shtml",
    "datetime": "2020-12-31 19:29:30",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药入选共建“一带一路”优秀实践案例",
    "href": "http://stock.jrj.com.cn/2020/12/25000031567714.shtml",
    "datetime": "2020-12-25 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药4名股东合计减持111.4万股 套现约2245.82万元",
    "href": "http://stock.jrj.com.cn/2020/12/11210631467277.shtml",
    "datetime": "2020-12-11 21:06:03",
    "code": "002019"
  },
  {
    "title": "亿帆医药(002019.SZ)：部分董事、高管已减持111.4万股",
    "href": "http://stock.jrj.com.cn/2020/12/11194131466746.shtml",
    "datetime": "2020-12-11 19:41:26",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药荣膺2020变革非凡雇主",
    "href": "http://stock.jrj.com.cn/2020/11/17000031298891.shtml",
    "datetime": "2020-11-17 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年前三季度净利9.11亿增长22.79% 信用减值损失同比下滑",
    "href": "http://stock.jrj.com.cn/2020/10/30103831173831.shtml",
    "datetime": "2020-10-30 10:38:23",
    "code": "002019"
  },
  {
    "title": "亿帆医药：国内重组人胰岛素的销售情况较去年有所增长",
    "href": "http://stock.jrj.com.cn/2020/10/22164731109300.shtml",
    "datetime": "2020-10-22 16:47:32",
    "code": "002019"
  },
  {
    "title": "安徽通报药品检查信息 亿帆医药安徽仁和药业已整改",
    "href": "http://stock.jrj.com.cn/2020/10/19175231084781.shtml",
    "datetime": "2020-10-19 17:52:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药与安徽医科大签定战略协议 深化多领域合作",
    "href": "http://stock.jrj.com.cn/2020/10/13000031048630.shtml",
    "datetime": "2020-10-13 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]第83届药交会在粤举行,亿帆医药携百品类参展交流",
    "href": "http://stock.jrj.com.cn/2020/09/29000030860227.shtml",
    "datetime": "2020-09-29 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：万春医药的普那布林属于联合治疗用药与公司在研项目F-627无直接竞争",
    "href": "http://stock.jrj.com.cn/2020/09/24090730822996.shtml",
    "datetime": "2020-09-24 09:07:58",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司在研项目F-627拟于2021年四季度在国内进行BLA",
    "href": "http://stock.jrj.com.cn/2020/09/14221430750107.shtml",
    "datetime": "2020-09-14 22:14:20",
    "code": "002019"
  },
  {
    "title": "亿帆医药：OncoImmune,Inc。的CD24fc属于免疫调节剂",
    "href": "http://stock.jrj.com.cn/2020/09/14221430750104.shtml",
    "datetime": "2020-09-14 22:14:11",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药杭州鑫富入选浙江大学重点服务企业名单",
    "href": "http://stock.jrj.com.cn/2020/09/04000030675533.shtml",
    "datetime": "2020-09-04 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年上半年净利7.18亿增长47.98% 维生素系列产品价格增幅较大",
    "href": "http://stock.jrj.com.cn/2020/08/31174530644355.shtml",
    "datetime": "2020-08-31 17:45:21",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药重庆鑫富获区政府表彰",
    "href": "http://stock.jrj.com.cn/2020/08/18000030528821.shtml",
    "datetime": "2020-08-18 00:00:00",
    "code": "002019"
  },
  {
    "title": "【龙虎榜】亿帆医药8月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/05180530434282.shtml",
    "datetime": "2020-08-05 18:05:52",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15083030245845.shtml",
    "datetime": "2020-07-15 08:30:08",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年上半年预计净利6.8亿元-8.25亿元 维生素B5价格上涨",
    "href": "http://stock.jrj.com.cn/2020/07/15001430242388.shtml",
    "datetime": "2020-07-15 00:14:50",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]公益捐赠 反哺乡梓——亿帆医药举办关爱城市守护人公益活动",
    "href": "http://stock.jrj.com.cn/2020/06/30000030096311.shtml",
    "datetime": "2020-06-30 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药旗下一企业研究院被认定为省级企业研究院",
    "href": "http://stock.jrj.com.cn/2020/06/17000029950213.shtml",
    "datetime": "2020-06-17 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药股东程先锋质押1400万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/06/10192129891814.shtml",
    "datetime": "2020-06-10 19:21:50",
    "code": "002019"
  },
  {
    "title": "沈阳圣元药品湖北抽检重量不合格 为亿帆医药子公司",
    "href": "http://stock.jrj.com.cn/2020/05/13145329660509.shtml",
    "datetime": "2020-05-13 14:53:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年一季度净利3.23亿增长119.79% 政府补助增加所致",
    "href": "http://stock.jrj.com.cn/2020/05/01190629440968.shtml",
    "datetime": "2020-05-01 19:06:13",
    "code": "002019"
  },
  {
    "title": "亿帆医药股东程先锋质押1400万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/04/15190229298130.shtml",
    "datetime": "2020-04-15 19:02:08",
    "code": "002019"
  },
  {
    "title": "亿帆医药2020年第一季度预计净利2.8亿元至3.38亿元 同比上升90%-130%",
    "href": "http://stock.jrj.com.cn/2020/04/15115129294662.shtml",
    "datetime": "2020-04-15 11:51:24",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292284.shtml",
    "datetime": "2020-04-15 08:00:11",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药旗下两家子公司获高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2020/04/10000029254660.shtml",
    "datetime": "2020-04-10 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药2019年净利润9.1亿元增长24% 海内外药品制剂业绩增长",
    "href": "http://stock.jrj.com.cn/2020/02/28100528911914.shtml",
    "datetime": "2020-02-28 10:05:33",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2019年净利9.11亿元 同比增长24%",
    "href": "http://stock.jrj.com.cn/2020/02/27214028909080.shtml",
    "datetime": "2020-02-27 21:40:14",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药40余万药品及物资 再援淮南战疫",
    "href": "http://stock.jrj.com.cn/2020/02/18000028847320.shtml",
    "datetime": "2020-02-18 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药40余万药品及物资 再援淮南战疫",
    "href": "http://stock.jrj.com.cn/2020/02/18000030647644.shtml",
    "datetime": "2020-02-18 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药鑫富科技工会荣获 2019年度临安区百家示范企业五星级工会组织",
    "href": "http://stock.jrj.com.cn/2020/02/17000028837644.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药再献爱心,五十余万抗疫药品及物资定向捐赠革命老区六安",
    "href": "http://stock.jrj.com.cn/2020/02/17000028837642.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：五十余万抗疫药品及物资定向捐赠革命老区六安",
    "href": "http://stock.jrj.com.cn/2020/02/09153528798167.shtml",
    "datetime": "2020-02-09 15:35:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药捐赠首批价值百万元药品抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/01/30182928743471.shtml",
    "datetime": "2020-01-30 18:29:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：捐赠首批百万药品 助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/01/30170528743275.shtml",
    "datetime": "2020-01-30 17:05:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药创新生物药取得重大进展",
    "href": "http://stock.jrj.com.cn/2020/01/08015728639651.shtml",
    "datetime": "2020-01-08 01:57:59",
    "code": "002019"
  },
  {
    "title": "亿帆医药子公司在研产品临床试验结果达到预设评价结果",
    "href": "http://stock.jrj.com.cn/2020/01/05191928627899.shtml",
    "datetime": "2020-01-05 19:19:33",
    "code": "002019"
  },
  {
    "title": "亿帆医药：子公司在研产品F-627中国III期临床试验结果达到预设评价结果",
    "href": "http://stock.jrj.com.cn/2020/01/05173028627788.shtml",
    "datetime": "2020-01-05 17:30:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]一路同行——亿帆医药2019皮肤科基层行完美收官",
    "href": "http://stock.jrj.com.cn/2020/01/02000028617421.shtml",
    "datetime": "2020-01-02 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]用心灵构建沟通桥梁——2019第三届青年医师学院培训会议成功举办",
    "href": "http://stock.jrj.com.cn/2020/01/02000028618868.shtml",
    "datetime": "2020-01-02 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：独家产品麻芩消咳颗粒首次纳入《国家医保目录》",
    "href": "http://stock.jrj.com.cn/2019/11/29193728470154.shtml",
    "datetime": "2019-11-29 19:37:22",
    "code": "002019"
  },
  {
    "title": "亿帆医药：独家产品麻芩消咳颗粒首次纳入《国家医保目录》",
    "href": "http://stock.jrj.com.cn/2019/11/29192528470118.shtml",
    "datetime": "2019-11-29 19:25:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：公司产品纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/29192128470107.shtml",
    "datetime": "2019-11-29 19:21:51",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]合肥亿帆生物医药荣登2019合肥服务业20强",
    "href": "http://stock.jrj.com.cn/2019/11/18000028412761.shtml",
    "datetime": "2019-11-18 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药控股子公司在研产品获得美国FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2019/10/23084928286354.shtml",
    "datetime": "2019-10-23 08:49:42",
    "code": "002019"
  },
  {
    "title": "早间公告：亿帆医药子公司在研产品获得美国FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2019/10/23082528286282.shtml",
    "datetime": "2019-10-23 08:25:37",
    "code": "002019"
  },
  {
    "title": "亿帆医药：子公司在研产品获得美国FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2019/10/23080528286234.shtml",
    "datetime": "2019-10-23 08:05:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：拟7.16亿元成为胰岛素制造商佰通公司第一大股东",
    "href": "http://stock.jrj.com.cn/2019/09/02213128077674.shtml",
    "datetime": "2019-09-02 21:31:20",
    "code": "002019"
  },
  {
    "title": "亿帆医药：拟7.16亿元取得胰岛素制造商佰通公司31.65%股权",
    "href": "http://stock.jrj.com.cn/2019/09/02212228077852.shtml",
    "datetime": "2019-09-02 21:22:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药2019年上半年盈利4.9亿 自产药品销售额增加",
    "href": "http://stock.jrj.com.cn/2019/08/26235928036621.shtml",
    "datetime": "2019-08-26 23:59:22",
    "code": "002019"
  },
  {
    "title": "亿帆医药：125个产品入选国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/22203428018687.shtml",
    "datetime": "2019-08-22 20:34:16",
    "code": "002019"
  },
  {
    "title": "亿帆医药：125个产品入选2019年版医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/22202628018651.shtml",
    "datetime": "2019-08-22 20:26:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药安庆鑫富荣获大观区2019年度民兵轮训备勤“先进单位”",
    "href": "http://stock.jrj.com.cn/2019/08/01000027915406.shtml",
    "datetime": "2019-08-01 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药顺利召开第三届博士后出站结题报告评审会",
    "href": "http://stock.jrj.com.cn/2019/07/22000027871551.shtml",
    "datetime": "2019-07-22 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药参展第三届中国中西融合皮肤科学大会",
    "href": "http://stock.jrj.com.cn/2019/07/19000027863350.shtml",
    "datetime": "2019-07-19 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药四川德峰药业获四川省诚信示范企业嘉誉",
    "href": "http://stock.jrj.com.cn/2019/07/16000027845995.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆亮相中药协会呼吸年会 复方银花卫星会成功举办",
    "href": "http://stock.jrj.com.cn/2019/07/16000027845994.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]缩宫素鼻喷雾剂赢临床专家认可 ——亿帆医药亮相2019年长三角围产医学学术会议",
    "href": "http://stock.jrj.com.cn/2019/07/15000027842657.shtml",
    "datetime": "2019-07-15 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：高端制剂项目处于设备验证阶段",
    "href": "http://stock.jrj.com.cn/2019/07/12104627830848.shtml",
    "datetime": "2019-07-12 10:46:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药亮相第十二届中华医学会生殖道感染峰会",
    "href": "http://stock.jrj.com.cn/2019/07/08000027810103.shtml",
    "datetime": "2019-07-08 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]2019年安医大四附院药剂科人员招聘录取名单公示",
    "href": "http://stock.jrj.com.cn/2019/05/31000027645369.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]2019年安医大四附院药剂科招聘笔试成绩公示",
    "href": "http://stock.jrj.com.cn/2019/05/16000027581043.shtml",
    "datetime": "2019-05-16 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药一季度净利1.47亿同比下滑55% 现金流量净额为-4657万元",
    "href": "http://stock.jrj.com.cn/2019/04/29082727505148.shtml",
    "datetime": "2019-04-29 08:27:02",
    "code": "002019"
  },
  {
    "title": "亿帆医药：带量采购全部执行有助公司自有产品快速上量",
    "href": "http://stock.jrj.com.cn/2019/04/09185727355926.shtml",
    "datetime": "2019-04-09 18:57:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药去年净利7.37亿同比降44% 董事长程先锋年薪60万元",
    "href": "http://stock.jrj.com.cn/2019/04/02192527309065.shtml",
    "datetime": "2019-04-02 19:25:20",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2018年净利同比下降43.5% 拟10派1元",
    "href": "http://stock.jrj.com.cn/2019/04/01213327297005.shtml",
    "datetime": "2019-04-01 21:33:04",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/29201027268722.shtml",
    "datetime": "2019-03-29 20:10:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药杭州鑫富科技取得知识产权管理体系证书",
    "href": "http://stock.jrj.com.cn/2019/03/25000027230094.shtml",
    "datetime": "2019-03-25 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安庆鑫富荣获“大观区2018年工业纳税贡献十强”称号",
    "href": "http://stock.jrj.com.cn/2019/02/21000027072134.shtml",
    "datetime": "2019-02-21 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]有情有“亿”——亿帆医药赴合肥紫蓬山敬老院慰问",
    "href": "http://stock.jrj.com.cn/2019/02/12000027033519.shtml",
    "datetime": "2019-02-12 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药大跌后举行电话会议：2018年发生大额商誉减值迹象的风险较小",
    "href": "http://stock.jrj.com.cn/2019/01/25211626982411.shtml",
    "datetime": "2019-01-25 21:16:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药重庆鑫富技术中心通过“市级技术中心” 认定",
    "href": "http://stock.jrj.com.cn/2019/01/02000026840857.shtml",
    "datetime": "2019-01-02 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药四川德峰药业荣获国家高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2018/12/07000025472650.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]宿州亿帆药业获得2018年首批高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2018/12/07000025472649.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药携公司部分品牌产品参展CDA年会",
    "href": "http://stock.jrj.com.cn/2018/11/16000025460648.shtml",
    "datetime": "2018-11-16 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]宿州亿帆风油精搽剂生产线GMP认证顺利通过",
    "href": "http://stock.jrj.com.cn/2018/11/13000025460637.shtml",
    "datetime": "2018-11-13 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]合肥亿帆生物医药荣膺2017年安徽民企纳税百强",
    "href": "http://stock.jrj.com.cn/2018/11/09000025460643.shtml",
    "datetime": "2018-11-09 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：7个主要品种新纳入国家基本药物目录",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/29080025270508.shtml",
    "datetime": "2018-10-29 08:00:01",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药杭州鑫富荣获“浙江省成长性最快百强企业”第二名",
    "href": "http://stock.jrj.com.cn/2018/10/29000025460639.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：7个主要品种新纳入国家基本药物目录",
    "href": "http://stock.jrj.com.cn/2018/10/26204825265924.shtml",
    "datetime": "2018-10-26 20:48:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/25225025260708.shtml",
    "datetime": "2018-10-25 22:50:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：控股公司创新型治疗用生物药获得临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/10/25201525260179.shtml",
    "datetime": "2018-10-25 20:15:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药半年报推10股派3元 股权登记9月25日",
    "href": "http://stock.jrj.com.cn/2018/09/18185225109173.shtml",
    "datetime": "2018-09-18 18:52:26",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药安庆鑫富化工荣获2017年度安徽省安康杯 “优胜班组”称号",
    "href": "http://stock.jrj.com.cn/2018/09/06000025460634.shtml",
    "datetime": "2018-09-06 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：上半年净利5.4亿同比增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/30075925023299.shtml",
    "datetime": "2018-08-30 07:59:55",
    "code": "002019"
  },
  {
    "title": "亿帆医药上半年净利同比增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2018/08/29213825021602.shtml",
    "datetime": "2018-08-29 21:38:25",
    "code": "002019"
  },
  {
    "title": "亿帆医药：上半年净利增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2018/08/29212025021537.shtml",
    "datetime": "2018-08-29 21:20:42",
    "code": "002019"
  },
  {
    "title": "亿帆医药：上半年净利增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2018/08/29212025021533.shtml",
    "datetime": "2018-08-29 21:20:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：关于非公开发行股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/08/23205024992888.shtml",
    "datetime": "2018-08-23 20:50:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆制药高端制剂项目顺利封顶",
    "href": "http://stock.jrj.com.cn/2018/08/14000025460649.shtml",
    "datetime": "2018-08-14 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]四川德峰获评眉山市A级质量信用企业",
    "href": "http://stock.jrj.com.cn/2018/08/13000025460636.shtml",
    "datetime": "2018-08-13 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药全新品牌形象全球首发",
    "href": "http://stock.jrj.com.cn/2018/08/01000025460646.shtml",
    "datetime": "2018-08-01 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]宿州亿帆酞丁安原料药生产线高质量通过10版GMP认证",
    "href": "http://stock.jrj.com.cn/2018/07/10000025460641.shtml",
    "datetime": "2018-07-10 00:00:00",
    "code": "002019"
  },
  {
    "title": "市场“寻医问药”亿帆医药接待逾百家机构",
    "href": "http://stock.jrj.com.cn/2018/06/11075224661567.shtml",
    "datetime": "2018-06-11 07:52:00",
    "code": "002019"
  },
  {
    "title": "市场“寻医问药” 亿帆医药接待逾百家机构",
    "href": "http://stock.jrj.com.cn/2018/06/11014224660605.shtml",
    "datetime": "2018-06-11 01:42:34",
    "code": "002019"
  },
  {
    "title": "亿帆医药拟要约收购新加坡一家生物医药公司不低于90%股份",
    "href": "http://stock.jrj.com.cn/2018/05/15214924544174.shtml",
    "datetime": "2018-05-15 21:49:11",
    "code": "002019"
  },
  {
    "title": "亿帆医药：拟要约收购新加坡一家生物医药公司逾90%股权",
    "href": "http://stock.jrj.com.cn/2018/05/15205024543846.shtml",
    "datetime": "2018-05-15 20:50:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/27224024468093.shtml",
    "datetime": "2018-04-27 22:40:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]倾听企业声音,助力保驾护航——合肥市长凌云莅临亿帆调研指导",
    "href": "http://stock.jrj.com.cn/2018/04/26000024454194.shtml",
    "datetime": "2018-04-26 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安徽省GSP检查员培训班至合肥亿帆生物开展现场检查模拟教学",
    "href": "http://stock.jrj.com.cn/2018/04/17000024403359.shtml",
    "datetime": "2018-04-17 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]重庆鑫富荣获重庆市长寿区2017年度“工业发展贡献企业”称号",
    "href": "http://stock.jrj.com.cn/2018/03/06000024198428.shtml",
    "datetime": "2018-03-06 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]春潮涌动 情暖寒冬——记亿帆医药辽宁圣元新春慰问活动",
    "href": "http://stock.jrj.com.cn/2018/02/28000024166043.shtml",
    "datetime": "2018-02-28 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]狮舞闹新春 锣鼓庆开年",
    "href": "http://stock.jrj.com.cn/2018/02/26000024152110.shtml",
    "datetime": "2018-02-26 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：F-627首个3期临床完成 未来利润空间广阔",
    "href": "http://stock.jrj.com.cn/hotstock/2018/01/29043024019734.shtml",
    "datetime": "2018-01-29 04:30:19",
    "code": "002019"
  },
  {
    "title": "月度机构调研动向：亿帆医药被147家机构扎堆调研",
    "href": "http://stock.jrj.com.cn/hotstock/2018/01/02141723883835.shtml",
    "datetime": "2018-01-02 14:17:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药：维生素B5等系列产品主要市场在欧美等地区",
    "href": "http://stock.jrj.com.cn/2017/12/07141823756297.shtml",
    "datetime": "2017-12-07 14:18:48",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药携多款产品亮相2017中华医学会围产学术会议",
    "href": "http://stock.jrj.com.cn/2017/09/29000023189851.shtml",
    "datetime": "2017-09-29 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]亿帆医药入选为中国医药上市公司最具竞争力20强和最具研发创新力10强",
    "href": "http://stock.jrj.com.cn/2017/09/23000023161754.shtml",
    "datetime": "2017-09-23 00:00:00",
    "code": "002019"
  },
  {
    "title": "天弘基金等近60家机构集体调研亿帆医药",
    "href": "http://stock.jrj.com.cn/2017/07/22103722784202.shtml",
    "datetime": "2017-07-22 10:37:51",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安徽医健投资管理有限公司 肥西县中医院 2017年第一批专业技术人员招聘合成成绩及拟录用人员公示",
    "href": "http://stock.jrj.com.cn/2017/03/29000024380297.shtml",
    "datetime": "2017-03-29 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安徽医健投资管理有限公司 肥西县中医院 2017年第一批专业技术人员招聘 面试成绩公告",
    "href": "http://stock.jrj.com.cn/2017/03/28000024380300.shtml",
    "datetime": "2017-03-28 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安徽医健投资管理有限公司 肥西县中医院 2017年第一批专业技术人员招聘 笔试成绩公告",
    "href": "http://stock.jrj.com.cn/2017/03/13000024380298.shtml",
    "datetime": "2017-03-13 00:00:00",
    "code": "002019"
  },
  {
    "title": "[亿帆医药]安徽医健投资管理有限公司 肥西县中医院 2017年第一批专业技术人员招聘实施方案",
    "href": "http://stock.jrj.com.cn/2017/02/28000024380296.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002019"
  },
  {
    "title": "亿帆医药非公开发行获审核通过",
    "href": "http://stock.jrj.com.cn/2017/01/18191221983280.shtml",
    "datetime": "2017-01-18 19:12:45",
    "code": "002019"
  },
  {
    "title": "亿帆医药三季报业绩同比增逾八成",
    "href": "http://stock.jrj.com.cn/2016/10/26190421623415.shtml",
    "datetime": "2016-10-26 19:04:56",
    "code": "002019"
  },
  {
    "title": "亿帆鑫富：对全资子公司增加投资暨增加注册资本",
    "href": "http://stock.jrj.com.cn/hotstock/2016/08/22075921347415.shtml",
    "datetime": "2016-08-22 07:59:59",
    "code": "002019"
  },
  {
    "title": "亿帆鑫富：定增收购海外公司股权 股价有望重上60日均线",
    "href": "http://stock.jrj.com.cn/2016/06/01230221026565.shtml",
    "datetime": "2016-06-01 23:02:32",
    "code": "002019"
  },
  {
    "title": "亿帆鑫富新年报喜 D-泛酸钙价格上涨助公司净利大增",
    "href": "http://stock.jrj.com.cn/2016/01/12013820394313.shtml",
    "datetime": "2016-01-12 01:38:00",
    "code": "002019"
  },
  {
    "title": "亿帆鑫富：公司医药类产品现内销为主",
    "href": "http://stock.jrj.com.cn/2015/12/25162520301236.shtml",
    "datetime": "2015-12-25 16:25:25",
    "code": "002019"
  },
  {
    "title": "泛酸钙市场价格继续提高至230元/KG 亿帆鑫富暴涨",
    "href": "http://stock.jrj.com.cn/2015/12/23144020286277.shtml",
    "datetime": "2015-12-23 14:40:00",
    "code": "002019"
  },
  {
    "title": "鑫富药业：拟设立香港孙公司拓展国际市场",
    "href": "http://stock.jrj.com.cn/hotstock/2014/09/22075918051218.shtml",
    "datetime": "2014-09-22 07:59:59",
    "code": "002019"
  },
  {
    "title": "鑫富药业：拟对湖州子公司实施债转股增加注册资本",
    "href": "http://stock.jrj.com.cn/hotstock/2014/05/28075917299841.shtml",
    "datetime": "2014-05-28 07:59:53",
    "code": "002019"
  },
  {
    "title": "快讯：鑫富药业股价再度跳水 午后触及跌停",
    "href": "http://stock.jrj.com.cn/2014/02/24134716733349.shtml",
    "datetime": "2014-02-24 13:47:45",
    "code": "002019"
  },
  {
    "title": "鑫富药业遭一股东连续大宗减持",
    "href": "http://stock.jrj.com.cn/2014/01/01184016427468.shtml",
    "datetime": "2014-01-01 18:40:00",
    "code": "002019"
  },
  {
    "title": "鑫富药业涨7.00%报16.05元",
    "href": "http://stock.jrj.com.cn/invest/2013/11/11143316124215.shtml",
    "datetime": "2013-11-11 14:33:00",
    "code": "002019"
  },
  {
    "title": "鑫富药业：对D-泛酸钙产品报价提高10%以上",
    "href": "http://stock.jrj.com.cn/hotstock/2013/11/07080016101741.shtml",
    "datetime": "2013-11-07 08:00:00",
    "code": "002019"
  },
  {
    "title": "鑫富药业：使用8000万元闲置募集资金暂时补充流动",
    "href": "http://stock.jrj.com.cn/hotstock/2013/11/07080016101738.shtml",
    "datetime": "2013-11-07 08:00:00",
    "code": "002019"
  },
  {
    "title": "机构游资高位追涨鑫富药业",
    "href": "http://stock.jrj.com.cn/hotstock/2013/08/22093215722155.shtml",
    "datetime": "2013-08-22 09:32:05",
    "code": "002019"
  },
  {
    "title": "快讯：鑫富药业资产重组 股价再次冲击涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/08/20103415710626.shtml",
    "datetime": "2013-08-20 10:34:22",
    "code": "002019"
  },
  {
    "title": "鑫富药业重组标的资产现高估值",
    "href": "http://stock.jrj.com.cn/2013/07/30083715602573.shtml",
    "datetime": "2013-07-30 08:37:27",
    "code": "002019"
  },
  {
    "title": "鑫富药业重组注入负资产 闪电重组或涉内幕交易",
    "href": "http://stock.jrj.com.cn/2013/07/26104815589385.shtml",
    "datetime": "2013-07-26 10:48:05",
    "code": "002019"
  },
  {
    "title": "快讯：鑫富药业转型生物医药 股价再次一字涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/07/26101715589110.shtml",
    "datetime": "2013-07-26 10:17:17",
    "code": "002019"
  },
  {
    "title": "鑫富药业抛17亿重组方案 收购对象业绩暴增28倍",
    "href": "http://stock.jrj.com.cn/2013/07/25011315580899.shtml",
    "datetime": "2013-07-25 01:13:25",
    "code": "002019"
  },
  {
    "title": "鑫富药业重组预案出炉 将变身生物医药企业",
    "href": "http://stock.jrj.com.cn/2013/07/24164715579648.shtml",
    "datetime": "2013-07-24 16:47:34",
    "code": "002019"
  },
  {
    "title": "东兴证券：鑫富药业 新材料业务渐有起色",
    "href": "http://stock.jrj.com.cn/hotstock/2013/06/03162015363334.shtml",
    "datetime": "2013-06-03 16:20:25",
    "code": "002019"
  },
  {
    "title": "鑫富药业控股股东通过约定购回式减持3.4%股份",
    "href": "http://stock.jrj.com.cn/2013/05/23200415331925.shtml",
    "datetime": "2013-05-23 20:04:46",
    "code": "002019"
  },
  {
    "title": "鑫富药业明日起“披星戴帽”多元战略失利欲“瘦身”",
    "href": "http://stock.jrj.com.cn/2012/04/26112712928404.shtml",
    "datetime": "2012-04-26 11:27:44",
    "code": "002019"
  },
  {
    "title": "鑫富药业：失手高分子项目 将“披星戴帽”",
    "href": "http://stock.jrj.com.cn/2012/04/26100712925215.shtml",
    "datetime": "2012-04-26 10:07:58",
    "code": "002019"
  },
  {
    "title": "鑫富药业龙虎榜数据一览(4/17)",
    "href": "http://stock.jrj.com.cn/hotstock/2012/04/17173512784330.shtml",
    "datetime": "2012-04-17 17:35:32",
    "code": "002019"
  },
  {
    "title": "传闻求证：鑫富药业将获稀土探矿权",
    "href": "http://stock.jrj.com.cn/hotstock/2012/03/23112512562284.shtml",
    "datetime": "2012-03-23 11:25:38",
    "code": "002019"
  },
  {
    "title": "鑫富药业弃子 元力食之有味",
    "href": "http://stock.jrj.com.cn/2012/03/15102412495306.shtml",
    "datetime": "2012-03-15 10:24:16",
    "code": "002019"
  },
  {
    "title": "壮士断腕迫于连续亏损 鑫富药业频处置存量资产",
    "href": "http://stock.jrj.com.cn/2012/03/14040612480436.shtml",
    "datetime": "2012-03-14 04:06:49",
    "code": "002019"
  },
  {
    "title": "鑫富药业：三季度有望扭亏 “强烈推荐”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2011/08/20002410798334.shtml",
    "datetime": "2011-08-20 00:24:55",
    "code": "002019"
  },
  {
    "title": "鑫富药业：处于业绩拐点 强烈推荐评级",
    "href": "http://stock.jrj.com.cn/hotstock/2011/06/11022510178684.shtml",
    "datetime": "2011-06-11 02:25:59",
    "code": "002019"
  },
  {
    "title": "鑫富药业：新材料业务高增长 强烈推荐",
    "href": "http://stock.jrj.com.cn/hotstock/2011/04/1403159725081.shtml",
    "datetime": "2011-04-14 03:15:39",
    "code": "002019"
  },
  {
    "title": "鑫富药业：目标价为20元 推荐评级",
    "href": "http://stock.jrj.com.cn/hotstock/2010/06/1804437634069.shtml",
    "datetime": "2010-06-18 04:43:10",
    "code": "002019"
  },
  {
    "title": "鑫富药业：VB5短期难以大幅提价",
    "href": "http://stock.jrj.com.cn/sme/2010/05/0607337412553.shtml",
    "datetime": "2010-05-06 07:33:00",
    "code": "002019"
  },
  {
    "title": "鑫富药业：不必过分担忧违约风险",
    "href": "http://stock.jrj.com.cn/sme/2010/05/0607277412492.shtml",
    "datetime": "2010-05-06 07:27:20",
    "code": "002019"
  },
  {
    "title": "鑫富药业参股投资汽车公司",
    "href": "http://stock.jrj.com.cn/sme/2010/03/3007427203250.shtml",
    "datetime": "2010-03-30 07:42:04",
    "code": "002019"
  },
  {
    "title": "鑫富药业：因产品售价降低 09年净利降26％",
    "href": "http://stock.jrj.com.cn/2010/01/2819456890594.shtml",
    "datetime": "2010-01-28 19:45:32",
    "code": "002019"
  },
  {
    "title": "鑫富药业商业秘密侵权案民事诉讼立案",
    "href": "http://stock.jrj.com.cn/sme/2010/01/2006536836513.shtml",
    "datetime": "2010-01-20 06:53:16",
    "code": "002019"
  }
]